In the multivariate Cox regression analysis, haptoglobin phenotype was independently associated with recurrence free survival (Hp 2-2; p = 0.0098), while for receptor status (ER/PR negative; p = 0.0962) and treatment arm (conventional dose; p = 0.0509) a borderline significant association was observed (Table 2 ).
← all excerpts
Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.
1
—
—